Toggle light / dark theme

Outcomes in Transplant Recipients With Advanced Cancers Receiving Immune Checkpoint Inhibitors

This systematic review and individual participant data met-analysis assesses the cancer-related and survival outcomes in solid organ transplant recipients with advanced-stage cancer treated with immune checkpoint inhibitors.

Leave a Comment

Lifeboat Foundation respects your privacy! Your email address will not be published.